Your browser doesn't support javascript.
loading
Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.
Sherman, Gilad; Lamb, Gabriella S; Sharma, Tanvi S; Lloyd, Elizabeth C; Nagel, Jerod; Dandam, Nada N; Oliveira, Carlos R; Sheikha, Hassan S; Anosike, Brenda I; Lee, Philip; Vora, Surabhi B; Patel, Karisma; Sue, Paul K; Rubbab, Beenish; Yarbrough, April M; Ganapathi, Lakshmi; Nakamura, Mari M.
Afiliação
  • Sherman G; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Lamb GS; Department of Pediatrics, Harvard Medical School.
  • Sharma TS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Lloyd EC; Department of Pediatrics, Harvard Medical School.
  • Nagel J; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Dandam NN; Department of Pediatrics, Harvard Medical School.
  • Oliveira CR; Department of Pediatrics, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
  • Sheikha HS; Department of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
  • Anosike BI; Department of Pharmacy, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
  • Lee P; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Vora SB; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Patel K; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
  • Sue PK; Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
  • Rubbab B; Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
  • Yarbrough AM; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Ganapathi L; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Nakamura MM; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
J Pediatric Infect Dis Soc ; 12(3): 152-155, 2023 Apr 18.
Article em En | MEDLINE | ID: mdl-36928172
ABSTRACT
Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article